标题
Evolving Concepts in Phases I and II Drug Development for Crohn’s Disease
作者
关键词
-
出版物
Journal of Crohns & Colitis
Volume 11, Issue 2, Pages 246-255
出版商
Oxford University Press (OUP)
发表日期
2016-08-04
DOI
10.1093/ecco-jcc/jjw137
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis
- (2016) Gaik W. Tew et al. GASTROENTEROLOGY
- Efficient Early Drug Development for Ulcerative Colitis
- (2016) Reena Khanna et al. GASTROENTEROLOGY
- Drug development in IBD: from novel target identification to early clinical trials
- (2016) Silvio Danese et al. GUT
- Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn’s Disease
- (2016) Elena Dubcenco et al. Journal of Crohns & Colitis
- Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
- (2016) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation
- (2015) A. J. F. Coimbra et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- C-Reactive Protein, Fecal Calprotectin and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
- (2015) Mahmoud H Mosli et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- 830 Initial Evaluation of MEDI2070 (Specific Anti-IL-23 Antibody) in Patients With Active Crohn's Disease Who Have Failed Anti-TNF Antibody Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 2A Induction Study
- (2015) Bruce E. Sands et al. GASTROENTEROLOGY
- 901a A Randomized, Multicenter Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in Patients With Moderate to Severe Ulcerative Colitis: Results of the TURANDOT Study
- (2015) Walter Reinisch et al. GASTROENTEROLOGY
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease
- (2015) Reena Khanna et al. GUT
- Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up
- (2015) Robert V Bryant et al. GUT
- Development and validation of a histological index for UC
- (2015) Mahmoud H Mosli et al. GUT
- Development and validation of the Nancy histological index for UC
- (2015) Aude Marchal-Bressenot et al. GUT
- The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
- (2015) Andres J Yarur et al. GUT
- Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohnʼs Disease
- (2015) Shringi Sharma et al. INFLAMMATORY BOWEL DISEASES
- Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD
- (2015) Konstantinos Papamichael et al. INFLAMMATORY BOWEL DISEASES
- Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease
- (2015) Janet R. Wade et al. JOURNAL OF CLINICAL PHARMACOLOGY
- OP021. TURANDOT: a randomized, multicenter double-blind, placebo-controlled study of the safety and efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in patients with moderate to severe Ulcerative Colitis (UC)
- (2015) Journal of Crohns & Colitis
- The changing landscape of phase I trials in oncology
- (2015) Kit Man Wong et al. Nature Reviews Clinical Oncology
- A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity
- (2014) R. Khanna et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
- (2014) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
- (2014) Niels Vande Casteele et al. GUT
- A phase II study of laquinimod in Crohn's disease
- (2014) Geert D'Haens et al. GUT
- Reproducibility of histological assessments of disease activity in UC
- (2014) Mahmoud H Mosli et al. GUT
- Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics
- (2014) A Jauregui-Amezaga et al. GUT
- Assessment of Histologic Disease Activity in Crohnʼs Disease
- (2014) Amirkaveh Mojtahed et al. INFLAMMATORY BOWEL DISEASES
- P176 Patient reported outcome measures derived from the Crohn's Disease Activity Index: Correlation between PRO2 and PRO3 scores and CDAI-defined clinical thresholds
- (2014) R. Khanna et al. Journal of Crohns & Colitis
- P284 Agreement of central readers in the evaluation of histopathological disease activity in ulcerative colitis
- (2014) M.H. Mosli et al. Journal of Crohns & Colitis
- DOP058 Pharmacokinetic and pharmacodynamic relationship and immunogenicity of vedolizumab in adults with inflammatory bowel disease: Additional results from the GEMINI 1 and 2 studies
- (2014) M. Rosario et al. Journal of Crohns & Colitis
- Clinical trials in luminal Crohn's disease: A historical perspective
- (2014) Pieter Hindryckx et al. Journal of Crohns & Colitis
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study
- (2014) Andrew Davies et al. LANCET ONCOLOGY
- The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome
- (2013) C. Lahiff et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcerative Colitis
- (2013) Brian G. Feagan et al. GASTROENTEROLOGY
- Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease
- (2013) Ingrid Ordás et al. GASTROENTEROLOGY
- European consensus on the histopathology of inflammatory bowel disease
- (2013) F. Magro et al. Journal of Crohns & Colitis
- Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
- (2013) J. Panes et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
- (2012) Paul Rutgeerts et al. GASTROENTEROLOGY
- Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol
- (2012) Xavier Hébuterne et al. GUT
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for crohnʼs perianal fistulas
- (2012) Phil Tozer et al. INFLAMMATORY BOWEL DISEASES
- Adaptive trial designs: a review of barriers and opportunities
- (2012) John A Kairalla et al. Trials
- Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease
- (2011) J. Panés et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's disease
- (2011) Karin Horsthuis et al. CLINICAL IMAGING
- Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials
- (2011) Adedigbo A. Fasanmade et al. CLINICAL THERAPEUTICS
- Non-perforating small bowel Crohn's disease assessed by MRI enterography: Derivation and histopathological validation of an MR-based activity index
- (2011) Michael J. Steward et al. EUROPEAN JOURNAL OF RADIOLOGY
- Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study
- (2011) Asit Parikh et al. INFLAMMATORY BOWEL DISEASES
- Population pharmacokinetics of golimumab in patients with ankylosing spondylitis: impact of body weight and immunogenicity
- (2011) Z.H. Xu et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Development of the Crohnʼs disease digestive damage score, the Lémann score
- (2010) Benjamin Pariente et al. INFLAMMATORY BOWEL DISEASES
- Adaptive Clinical Trials: The Promise and the Caution
- (2010) Donald A. Berry JOURNAL OF CLINICAL ONCOLOGY
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI
- (2009) Alain M Schoepfer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease
- (2009) J. Rimola et al. GUT
- The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti- 4 7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
- (2009) D. Soler et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
- (2008) Edward Keystone et al. ARTHRITIS AND RHEUMATISM
- Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
- (2008) Gert Van Assche et al. GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started